Doug Fulling President
Today’s healthcare world presents a fast-moving, highly complex, many phased picture. From market-sizing all the way through to sales compensation and payer reimbursement, data abounds adding to the complexity. But if you want to make fully informed decisions around how to maximize brand performance, or how to optimize the sales team’s time and message, you need information that captures real-world dynamics and turns them to your advantage.
Symphony Health provides thorough data and powerful analytics to help professionals understand the full market lifecycle, from predictive market analysis to patient influence, physician prescribing, pharmacy fulfillment, payer reimbursement, and sales compensation. This holistic perspective can only be attained from a massive base of fully integrated information that captures physician, payer, and patient actions.
We help you turn questions into answers, answers into decisions, and decisions into success.
At Symphony Health, we believe it is critical for major participants in the healthcare industry to transform their commercial approaches centered around informed, insightful research and thorough analysis that is accessed via powerful technology.
Symphony Health was created to help customers dramatically improve their performance, productivity, and profitability by delivering high-value data, analytics, and innovative performance solutions using our unique data and research capabilities. Formed in 2012, Symphony Health offers the best in innovative research services for the life sciences industry. A pioneer in the physician-level targeting environment that pharmaceutical companies use today, Symphony Health provides strategic market data that analyzes the industry from the perspectives of providers, payers, and patients to a variety of private and public organizations.
Symphony Health is owned by PRA Health Sciences, one of the world’s leading global contract research organizations, or CROs, by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes more than 90 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East and over 16,000 employees worldwide. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 70 drugs.